Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of tadalafil 5 mg once‐daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double‐blind, parallel, placebo‐ and tamsulosin‐controlled study

Published:2018-10-25 Issue:2 Volume:26 Page:192-200
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Zhang Zhichao¹,Li Hanzhong²,Zhang Xiaodong³,Dai Yutian⁴,Park Hyun Jun⁵,Jiann Bang‐Ping⁶,Li Peng⁷,Lou Ying⁷,Ye Zhangqun⁸,Viktrup Lars⁹

Affiliation:

1. Andrology Center Peking University First Hospital Peking University Beijing China

2. Peking Union Medical College Hospital Beijing China

3. Beijing Chaoyang Hospital Capital Medical University Beijing China

4. Nanjing Drum Tower Hospital Nanjing Jiangsu China

5. Department of Urology Pusan National University Hospital Busan Korea

6. Kaohsiung Veterans General Hospital Kaohsiung Taiwan

7. Eli Lilly Suzhou Pharmaceutical Shanghai China

8. Department of Urology Tongji Hospital Tongji Medical College of Huazhong University of Science and Technology Wuhan Hubei China

9. Lilly Research Laboratories Eli Lilly and Company, Indianapolis Indiana USA

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.13828

Reference28 articles.

1. Impact of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Treatment with Tamsulosin and Solifenacin Combination Therapy on Erectile Function

2. Coexisting lower urinary tract symptoms and erectile dysfunction: a systematic review of epidemiological data

3. The Link Between LUTS and ED: Clinical and Basic Science Evidence

4. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conservative Non-surgical Options for Erectile Dysfunction;Current Urology Reports;2022-11-29

2. Discontinuation Rates of Tadalafil Alone and in Combination with a-Blockers in the Treatment of Male Lower Urinary Tract Symptoms with or without Coexisting Erectile Dysfunction: A Systematic Review and Meta-Analysis;International Journal of Clinical Practice;2022-11-03

3. Efficacy of tadalafil on symptom‐specific bother in men with lower urinary tract symptoms;LUTS: Lower Urinary Tract Symptoms;2022-07-13

4. Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-03-07

5. Efficacy and Safety of 12-week Monotherapy With Once Daily 5 mg Tadalafil for Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: Evidence-based Analysis;Frontiers in Medicine;2021-10-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3